MedGen, Inc. (MDIN)

USD 0.0

(0.0%)

EBITDA Summary of MedGen, Inc.

  • MedGen, Inc.'s latest annual EBITDA in 2019 was -15.37 USD , down 0.0% from previous year.
  • MedGen, Inc.'s latest quarterly EBITDA in 2019 FY was N/A , down 0.0% from previous quarter.
  • MedGen, Inc. reported an annual EBITDA of -2670.00 USD in 2017, up 98.43% from previous year.
  • MedGen, Inc. reported an annual EBITDA of -170 Thousand USD in 2016, down 0.0% from previous year.
  • MedGen, Inc. reported a quarterly EBITDA of N/A for 2017 FY, up 98.43% from previous quarter.
  • MedGen, Inc. reported a quarterly EBITDA of N/A for 2016 FY, down 0.0% from previous quarter.

Annual EBITDA Chart of MedGen, Inc. (2019 - 2016)

Historical Annual EBITDA of MedGen, Inc. (2019 - 2016)

Year EBITDA EBITDA Growth
2019 -15.37 USD 0.0%
2017 -2670.00 USD 98.43%
2016 -170 Thousand USD 0.0%

Peer EBITDA Comparison of MedGen, Inc.

Name EBITDA EBITDA Difference
Alternative Energy Partners, Inc. -251.11 USD 93.879%
Allstar Health Brands, Inc. -241.78 Thousand USD 99.994%
Beijing Tong Ren Tang Chinese Medicine Company Limited 89.4 Million USD 100.0%
Café Serendipity Holdings, Inc. -1.41 Million USD 99.999%
Decision Diagnostics Corp. - USD Infinity%
Health Advance Inc. -47.95 Thousand USD 99.968%
HealthWarehouse.com, Inc. -1.27 Million USD 99.999%
LIGAND PHARMACEUTICAL INC 47.23 Million USD 100.0%
Omni Health, Inc. 1.28 Million USD 100.001%
Oxford Investments Holdings Inc. -343.96 Thousand USD 99.996%
Pineapple, Inc. -1.47 Million USD 99.999%
ScripsAmerica, Inc. -3.95 Million USD 100.0%